Reply To: Coronavirus impact on new trials
April 30, 2020 at 9:16 pmOur company has put a hold on new enrollment for existing studies and delayed the start up of new studies in an effort to respect the priorities of the investigators being on COVID-19. The exception would be our oncology trials which have not been paused or delayed start ups although enrollment is slow at the moment.
